ALGS

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Aligos Therapeutics Inc

NASDAQ | ALGS

7.92

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 18, 2025)

$48.74M

Market Cap

-

P/E Ratio

-13.54

EPS

$46.80

52 Week High

$3.76

52 Week Low

HEALTHCARE

Sector

ALGS Chart

Recent Chart
Price Action

ALGS Technicals

Tags:

ALGS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.9M
Total Revenue $3.9M
Cost Of Revenue $2.6M
Costof Goods And Services Sold $2.6M
Operating Income -$89M
Selling General And Administrative $23M
Research And Development $70M
Operating Expenses $93M
Investment Income Net -
Net Interest Income $4.4M
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.6M
Income Before Tax -$131M
Income Tax Expense $331K
Interest And Debt Expense -
Net Income From Continuing Operations -$131M
Comprehensive Income Net Of Tax -
Ebit -$89M
Ebitda -$87M
Net Income -$131M

Revenue & Profitability

Earnings Performance

ALGS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $70M
Total Current Assets $62M
Cash And Cash Equivalents At Carrying Value $37M
Cash And Short Term Investments $37M
Inventory -
Current Net Receivables -
Total Non Current Assets $8M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $20M
Other Current Assets $5.2M
Other Non Current Assets -
Total Liabilities $99M
Total Current Liabilities $22M
Current Accounts Payable $2.6M
Deferred Revenue -
Current Debt -
Short Term Debt $3.5M
Total Non Current Liabilities $79M
Capital Lease Obligations $8.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $8.4M
Other Current Liabilities $16M
Other Non Current Liabilities $46K
Total Shareholder Equity -$29M
Treasury Stock -
Retained Earnings -$618M
Common Stock $8K
Common Stock Shares Outstanding $6.3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$81M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.6M
Capital Expenditures $130K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$18M
Cashflow From Financing $355K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$131M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.9M
Total Revenue $3.9M
Cost Of Revenue $2.6M
Costof Goods And Services Sold $2.6M
Operating Income -$89M
Selling General And Administrative $23M
Research And Development $70M
Operating Expenses $93M
Investment Income Net -
Net Interest Income $4.4M
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.6M
Income Before Tax -$131M
Income Tax Expense $331K
Interest And Debt Expense -
Net Income From Continuing Operations -$131M
Comprehensive Income Net Of Tax -
Ebit -$89M
Ebitda -$87M
Net Income -$131M

ALGS News

ALGS Profile

Aligos Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Aligos Therapeutics, Inc. (ALGS) is a dynamic clinical-stage biopharmaceutical company based in South San Francisco, California, focused on developing innovative therapies for viral infections and liver diseases. Its extensive pipeline features candidates for chronic hepatitis B and liver fibrosis, underscoring the company's commitment to addressing critical unmet medical needs through advanced scientific approaches and strategic collaborations. Aligos's dedication to pioneering transformative healthcare solutions positions it as a compelling investment opportunity for institutional investors seeking growth in the biopharmaceutical sector.

LPTX
+368.57%
$2.05
AZI
+11.98%
$0.08
FRGT
+36.34%
$0.90
NVDA
+2.84%
$186.52
PLUG
-11.21%
$1.90
CHR
+20.54%
$0.05
ONDS
-4.33%
$7.50
LOBO
+27.77%
$0.50
SGBX
+78.00%
$6.07
ZYXI
+32.14%
$0.55
VHAI
-33.33%
$0.00
ABEV
-2.76%
$2.46
NOK
-9.11%
$6.03
DNN
+2.10%
$2.43
ASST
-6.25%
$1.05
TSLA
+0.68%
$403.99
AXDX
-61.36%
$0.03
IVP
-58.73%
$0.11
INTC
+2.27%
$35.11
WTO
-15.94%
$0.02
SOFI
+1.82%
$26.72
PFE
-2.16%
$24.90
NUVB
+48.95%
$7.15
TLRY
-6.60%
$0.96
ACHR
+2.56%
$7.61
SNAP
+0.85%
$8.25
AMZN
+0.06%
$222.69
BITF
-4.18%
$2.63
PCG
-2.72%
$15.71
EOSE
-5.19%
$12.78
RIVN
-1.80%
$14.72
ADAP
-15.14%
$0.05
BMNR
-9.89%
$29.08
GOOGL
-0.25%
$284.28
BYND
-0.45%
$0.99
AAL
-0.04%
$12.35
WBD
-2.53%
$23.09
ETHD
+13.86%
$5.95
NIO
-3.84%
$5.75
PLTR
-1.14%
$165.42
SEMR
+73.96%
$11.76
NFLX
+3.44%
$114.09
MARA
-5.97%
$11.16
AMD
-3.35%
$222.57
GOOG
+2.81%
$292.99
WULF
+1.91%
$12.23
EPWK
+24.63%
$1.72
F
-0.96%
$12.89
RMBL
+60.50%
$3.21
RGTI
-0.97%
$25.46
AAPL
+0.41%
$268.56
LNW
-3.71%
$86.22
CAN
-6.54%
$0.96
IREN
-6.18%
$45.83
ADD
-25.47%
$0.05
CIFR
+0.27%
$14.62
BURU
-5.42%
$0.20
QBTS
+2.22%
$23.44
SRM
+53.27%
$10.30
CLF
+2.00%
$11.19
MSFT
-2.69%
$493.79
T
-1.30%
$25.26
TWOH
+12.00%
$0.00
OWL
-0.79%
$13.80
QUBT
-6.32%
$11.56
GRAB
-0.18%
$5.31
BTBT
-9.24%
$2.16
STEC
+38.81%
$1.05
BBD
-0.55%
$3.60
PLTD
+1.26%
$7.21
MU
-0.38%
$227.60
RIG
-0.60%
$4.10
WLGS
-5.57%
$0.04
CRCL
-9.16%
$69.58
MTSR
-0.35%
$70.50
ASBP
-6.24%
$0.09
SMCI
-3.35%
$33.73
RXRX
-3.12%
$4.03
BMNU
-18.13%
$6.90
CGTL
-11.32%
$0.71
DVLT
-8.57%
$1.60
CLSK
+1.88%
$10.81
KZIA
+42.36%
$8.20
BTE
+1.91%
$3.20
BTG
-0.62%
$3.96
HBAN
+0.35%
$15.40
META
-1.23%
$590.32
KVUE
-0.80%
$16.10
SOUN
+0.86%
$11.63
PYPL
-0.97%
$60.11
QS
-3.85%
$12.47
AFMD
-34.94%
$0.18
VSA
+3.00%
$0.17
MSTR
-10.37%
$185.33
AMC
+0.46%
$2.18
WMT
-0.79%
$100.58
MDT
+4.69%
$100.80
APLD
+3.03%
$23.53
NGD
+2.30%
$7.11
VZ
-0.69%
$41.19
LPTX
+368.57%
$2.05
AZI
+11.98%
$0.08
FRGT
+36.34%
$0.90
NVDA
+2.84%
$186.52
PLUG
-11.21%
$1.90
CHR
+20.54%
$0.05
ONDS
-4.33%
$7.50
LOBO
+27.77%
$0.50
SGBX
+78.00%
$6.07
ZYXI
+32.14%
$0.55
VHAI
-33.33%
$0.00
ABEV
-2.76%
$2.46
NOK
-9.11%
$6.03
DNN
+2.10%
$2.43
ASST
-6.25%
$1.05
TSLA
+0.68%
$403.99
AXDX
-61.36%
$0.03
IVP
-58.73%
$0.11
INTC
+2.27%
$35.11
WTO
-15.94%
$0.02
SOFI
+1.82%
$26.72
PFE
-2.16%
$24.90
NUVB
+48.95%
$7.15
TLRY
-6.60%
$0.96
ACHR
+2.56%
$7.61
SNAP
+0.85%
$8.25
AMZN
+0.06%
$222.69
BITF
-4.18%
$2.63
PCG
-2.72%
$15.71
EOSE
-5.19%
$12.78
RIVN
-1.80%
$14.72
ADAP
-15.14%
$0.05
BMNR
-9.89%
$29.08
GOOGL
-0.25%
$284.28
BYND
-0.45%
$0.99
AAL
-0.04%
$12.35
WBD
-2.53%
$23.09
ETHD
+13.86%
$5.95
NIO
-3.84%
$5.75
PLTR
-1.14%
$165.42
SEMR
+73.96%
$11.76
NFLX
+3.44%
$114.09
MARA
-5.97%
$11.16
AMD
-3.35%
$222.57
GOOG
+2.81%
$292.99
WULF
+1.91%
$12.23
EPWK
+24.63%
$1.72
F
-0.96%
$12.89
RMBL
+60.50%
$3.21
RGTI
-0.97%
$25.46
AAPL
+0.41%
$268.56
LNW
-3.71%
$86.22
CAN
-6.54%
$0.96
IREN
-6.18%
$45.83
ADD
-25.47%
$0.05
CIFR
+0.27%
$14.62
BURU
-5.42%
$0.20
QBTS
+2.22%
$23.44
SRM
+53.27%
$10.30
CLF
+2.00%
$11.19
MSFT
-2.69%
$493.79
T
-1.30%
$25.26
TWOH
+12.00%
$0.00
OWL
-0.79%
$13.80
QUBT
-6.32%
$11.56
GRAB
-0.18%
$5.31
BTBT
-9.24%
$2.16
STEC
+38.81%
$1.05
BBD
-0.55%
$3.60
PLTD
+1.26%
$7.21
MU
-0.38%
$227.60
RIG
-0.60%
$4.10
WLGS
-5.57%
$0.04
CRCL
-9.16%
$69.58
MTSR
-0.35%
$70.50
ASBP
-6.24%
$0.09
SMCI
-3.35%
$33.73
RXRX
-3.12%
$4.03
BMNU
-18.13%
$6.90
CGTL
-11.32%
$0.71
DVLT
-8.57%
$1.60
CLSK
+1.88%
$10.81
KZIA
+42.36%
$8.20
BTE
+1.91%
$3.20
BTG
-0.62%
$3.96
HBAN
+0.35%
$15.40
META
-1.23%
$590.32
KVUE
-0.80%
$16.10
SOUN
+0.86%
$11.63
PYPL
-0.97%
$60.11
QS
-3.85%
$12.47
AFMD
-34.94%
$0.18
VSA
+3.00%
$0.17
MSTR
-10.37%
$185.33
AMC
+0.46%
$2.18
WMT
-0.79%
$100.58
MDT
+4.69%
$100.80
APLD
+3.03%
$23.53
NGD
+2.30%
$7.11
VZ
-0.69%
$41.19
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.